Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-12-07 5:06 pm Sale | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,894,831 8.9% | -20,444 (-1.07%) | View |
| 2020-11-30 5:05 pm Purchase | 13G | F-STAR THERAPEUTICS INC FSTX | GSK plc GSK | 803,922 8.9% | 803,922 (New Position) | View |
| 2020-11-06 5:26 pm Purchase | 13D | TURNING PT THERAPEUTICS INC CO TPTX | GSK plc GSK | 2,273,618 4.9% | 4,958 (+0.22%) | View |
| 2020-09-30 9:00 pm Sale | 13D | PRINCIPIA BIOPHARMA INC PRNB | GSK plc GSK | 0 0% | -3,042,193 (Position Closed) | View |
| 2020-08-24 4:12 pm Purchase | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | GSK plc GSK | 14,935,721 8.4% | 14,935,721 (New Position) | View |
| 2020-07-31 5:39 pm Purchase | 13D | PANDION THERAPEUTICS INC PAND | GSK plc GSK | 2,262,301 7.9% | 2,262,301 (New Position) | View |
| 2020-07-22 5:23 pm Purchase | 13D | NKARTA INC NKTX | GSK plc GSK | 3,161,432 9.7% | 3,161,432 (New Position) | View |
| 2020-07-10 5:26 pm Purchase | 13D | CRISPR THERAPEUTICS AG NAMEN A CRSP | GSK plc GSK | 3,310,627 4.8% | 15,000 (+0.46%) | View |
| 2020-06-29 6:17 pm Sale | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 1,431,551 4.7% | -102,221 (-6.66%) | View |
| 2020-06-22 5:13 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 15.3% | 0 (Unchanged) | View |
| 2020-06-17 4:07 pm Sale | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 15.3% | -1 (-0.00%) | View |
| 2020-06-04 5:03 pm Sale | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 1,819,478 8.8% | -114,528 (-5.92%) | View |
| 2020-05-26 5:06 pm Purchase | 13D | TURNING PT THERAPEUTICS INC CO TPTX | GSK plc GSK | 2,268,660 5.5% | 276,110 (+13.86%) | View |
| 2020-05-04 4:18 pm Purchase | 13G | VIR BIOTECHNOLOGY INC VIR | GSK plc GSK | 6,626,027 6.03% | 6,626,027 (New Position) | View |
| 2020-02-28 4:48 pm Unchanged | 13G | GENOCEA BIOSCIENCES INC GNCA | GSK plc GSK | 3,676,767 13.3% | 0 (Unchanged) | View |
| 2020-02-27 4:48 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,808 15.5% | 0 (Unchanged) | View |
| 2020-02-18 4:37 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,808 15.5% | 0 (Unchanged) | View |
| 2020-02-18 4:35 pm Sale | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 1,533,772 5% | -1,100,000 (-41.77%) | View |
| 2020-02-14 5:01 pm Unchanged | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | GSK plc GSK | 1,179,941 4.1% | 0 (Unchanged) | View |
| 2020-02-14 4:40 pm Sale | 13D | TRANSLATE BIO INC TBIO | GSK plc GSK | 646,541 1.1% | -2,551,372 (-79.78%) | View |